Compositions and Methods Modulating Mg29 for the Treatment of Diabetes

Disclosed herein are compositions and methods for treatment of muscle dysfunction, including diabetes. In addition, the invention relates to therapeutic compositions comprising nucleotides and/or polypeptides of the invention in combination with a pharmaceutically acceptable carrier, wherein the composition facilitates the treatment of skeletal musle disorders. Moreover, the invention relates to the treatment and/or prevention of pathological conditions associated with altered intracellular Ca2+ reulgation and disrupted membrane structure that occurs when the expression levels of MG29 are reduced.

Attached files:


Patents:
WO 2,010,141,810

Inventor(s): LIN PEIHUI [US]; MA JIANJIE [US]; WEISLEDER NOAH [US]; ZHU HUA [US]

Type of Offer: Licensing



« More Pharmaceutical Patents
« More Medical Patents

---